Scholtz & Company’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-70,750
Closed -$3.28M 43
2016
Q1
$3.28M Buy
70,750
+20,560
+41% +$992K 3.27% 16
2015
Q4
$2.71M Buy
50,190
+10,180
+25% +$490K 2.86% 12
2015
Q3
$1.61M Buy
+40,010
New +$2.23M 1.72% 27

Other funds holding VTRS

Scholtz & Company's VTRS Position: Q2 2016 in Review

Scholtz & Company sold out of Viatris (VTRS) in Q2 2016, closing a stake of 70,750 shares — an estimated $3.28M sold.

Scholtz & Company first reported a position in VTRS in Q3 2015 and held it in 3 quarters. The position peaked at $3.28M in Q1 2016. 577 funds tracked by Wall St. Rank hold VTRS as of Q2 2016.

  • Scholtz & Company reported no remaining Viatris position as of Q2 2016 after selling out during the quarter.
  • Scholtz & Company sold 70,750 Viatris shares in Q2 2016, an estimated $3.28M.
  • Scholtz & Company first reported a position in Viatris in Q3 2015 and held it in 3 quarters.
  • Scholtz & Company's Viatris position peaked at $3.28M in Q1 2016.
  • 577 funds tracked by Wall St. Rank held Viatris as of Q2 2016.

Based on Scholtz & Company's 13F filing for Q2 2016, filed 15 Aug 2016.